HUP0004139A3 - Compositions of lipid lowering agents containing water-soluble polimer - Google Patents
Compositions of lipid lowering agents containing water-soluble polimerInfo
- Publication number
- HUP0004139A3 HUP0004139A3 HU0004139A HUP0004139A HUP0004139A3 HU P0004139 A3 HUP0004139 A3 HU P0004139A3 HU 0004139 A HU0004139 A HU 0004139A HU P0004139 A HUP0004139 A HU P0004139A HU P0004139 A3 HUP0004139 A3 HU P0004139A3
- Authority
- HU
- Hungary
- Prior art keywords
- polimer
- soluble
- compositions
- containing water
- agents containing
- Prior art date
Links
- 239000003524 antilipemic agent Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203407 | 1997-11-03 | ||
| PCT/EP1998/006998 WO1999022738A1 (en) | 1997-11-03 | 1998-10-27 | Compositions of lipid lowering agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004139A2 HUP0004139A2 (hu) | 2002-02-28 |
| HUP0004139A3 true HUP0004139A3 (en) | 2002-03-28 |
Family
ID=8228898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004139A HUP0004139A3 (en) | 1997-11-03 | 1998-10-27 | Compositions of lipid lowering agents containing water-soluble polimer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6342245B1 (hu) |
| EP (1) | EP1028730B1 (hu) |
| JP (1) | JP2001521899A (hu) |
| KR (2) | KR20010023661A (hu) |
| CN (1) | CN1278175A (hu) |
| AR (1) | AR013739A1 (hu) |
| AT (1) | ATE216238T1 (hu) |
| AU (1) | AU746890B2 (hu) |
| BG (1) | BG104338A (hu) |
| BR (1) | BR9814109A (hu) |
| CA (1) | CA2307097A1 (hu) |
| DE (1) | DE69804994D1 (hu) |
| EE (1) | EE200000186A (hu) |
| HU (1) | HUP0004139A3 (hu) |
| NO (1) | NO20002279L (hu) |
| NZ (1) | NZ503413A (hu) |
| PL (1) | PL340305A1 (hu) |
| SK (1) | SK5972000A3 (hu) |
| WO (1) | WO1999022738A1 (hu) |
| ZA (1) | ZA989997B (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE444060T1 (de) | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
| US20030059487A1 (en) * | 2001-09-21 | 2003-03-27 | Niazi Sarfaraz K. | Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| US20040220240A1 (en) * | 2001-11-28 | 2004-11-04 | Pellegrini Cara A. | Method of increasing the extent of absorption of tizanidine |
| US6455557B1 (en) * | 2001-11-28 | 2002-09-24 | Elan Pharmaceuticals, Inc. | Method of reducing somnolence in patients treated with tizanidine |
| NZ546183A (en) * | 2003-09-26 | 2011-04-29 | Alza Corp | Controlled release formulations exhibiting an ascending rate of release |
| ATE504288T1 (de) * | 2003-09-26 | 2011-04-15 | Alza Corp | Oros-push-stick für die kontrollierte abgabe von wirkstoffen |
| JP5563731B2 (ja) * | 2003-09-26 | 2014-07-30 | アルザ・コーポレーシヨン | オピオイドおよび非オピオイド鎮痛薬の制御放出製剤 |
| JP4919801B2 (ja) * | 2003-09-26 | 2012-04-18 | アルザ・コーポレーシヨン | 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法 |
| CN101664411A (zh) | 2003-11-14 | 2010-03-10 | 味之素株式会社 | 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂 |
| WO2005097131A2 (en) * | 2004-04-09 | 2005-10-20 | Janssen Pharmaceutica N.V. | Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors |
| WO2005117834A1 (en) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Solid dispersions of a basic drug compound and a polymer containing acidic groups |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| CA2609783A1 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US20090028938A1 (en) * | 2005-08-08 | 2009-01-29 | Abbott Gmbh & Co. Kg | Dosage forms with improved bioavailability |
| EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2010143199A1 (en) | 2009-06-11 | 2010-12-16 | Suven Nishtaa Pharma Private Limited | Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO118715B1 (ro) * | 1994-10-27 | 2003-09-30 | Janssen Pharmaceutica Nv | Inhibitori ai sintezei apolipoproteinei-b |
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
-
1998
- 1998-10-27 EP EP98954483A patent/EP1028730B1/en not_active Expired - Lifetime
- 1998-10-27 DE DE69804994T patent/DE69804994D1/de not_active Expired - Lifetime
- 1998-10-27 WO PCT/EP1998/006998 patent/WO1999022738A1/en not_active Application Discontinuation
- 1998-10-27 EE EEP200000186A patent/EE200000186A/xx unknown
- 1998-10-27 PL PL98340305A patent/PL340305A1/xx unknown
- 1998-10-27 KR KR1020007002314A patent/KR20010023661A/ko not_active Application Discontinuation
- 1998-10-27 SK SK597-2000A patent/SK5972000A3/sk unknown
- 1998-10-27 NZ NZ503413A patent/NZ503413A/en unknown
- 1998-10-27 JP JP2000518671A patent/JP2001521899A/ja not_active Withdrawn
- 1998-10-27 AT AT98954483T patent/ATE216238T1/de not_active IP Right Cessation
- 1998-10-27 BR BR9814109-0A patent/BR9814109A/pt not_active IP Right Cessation
- 1998-10-27 CN CN98810808A patent/CN1278175A/zh active Pending
- 1998-10-27 US US09/530,170 patent/US6342245B1/en not_active Expired - Fee Related
- 1998-10-27 HU HU0004139A patent/HUP0004139A3/hu unknown
- 1998-10-27 KR KR1020007002383A patent/KR20010023729A/ko active Search and Examination
- 1998-10-27 CA CA002307097A patent/CA2307097A1/en not_active Abandoned
- 1998-10-27 AU AU11576/99A patent/AU746890B2/en not_active Ceased
- 1998-11-02 AR ARP980105502A patent/AR013739A1/es not_active Application Discontinuation
- 1998-11-02 ZA ZA9809997A patent/ZA989997B/xx unknown
-
2000
- 2000-04-14 BG BG104338A patent/BG104338A/xx unknown
- 2000-04-28 NO NO20002279A patent/NO20002279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1028730A1 (en) | 2000-08-23 |
| AU1157699A (en) | 1999-05-24 |
| WO1999022738A1 (en) | 1999-05-14 |
| NZ503413A (en) | 2001-06-29 |
| SK5972000A3 (en) | 2000-12-11 |
| KR20010023661A (ko) | 2001-03-26 |
| US6342245B1 (en) | 2002-01-29 |
| PL340305A1 (en) | 2001-01-29 |
| DE69804994D1 (de) | 2002-05-23 |
| BR9814109A (pt) | 2000-10-03 |
| JP2001521899A (ja) | 2001-11-13 |
| NO20002279D0 (no) | 2000-04-28 |
| NO20002279L (no) | 2000-04-28 |
| BG104338A (en) | 2000-12-29 |
| ATE216238T1 (de) | 2002-05-15 |
| KR20010023729A (ko) | 2001-03-26 |
| EP1028730B1 (en) | 2002-04-17 |
| AR013739A1 (es) | 2001-01-10 |
| HUP0004139A2 (hu) | 2002-02-28 |
| EE200000186A (et) | 2001-04-16 |
| CN1278175A (zh) | 2000-12-27 |
| AU746890B2 (en) | 2002-05-02 |
| CA2307097A1 (en) | 1999-05-14 |
| ZA989997B (en) | 2000-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004139A3 (en) | Compositions of lipid lowering agents containing water-soluble polimer | |
| IL136086A0 (en) | New composition of matter | |
| HUP9903759A3 (en) | Abtimicrobial compositions | |
| PL341372A1 (en) | Cellecoxibe containing compositions | |
| ZA984127B (en) | New composition of matter | |
| EP1020194A4 (en) | OIL / WATER EMULSION COMPILATIONS | |
| PL338186A1 (en) | Beneficial agent compositions containing alpha-hydroxyesters | |
| HK1034193A1 (en) | Compositions for weight reduction | |
| PL334568A1 (en) | Paroxetin containing compositions | |
| PL336264A1 (en) | Hypochlorite-type bleaching compositions | |
| HUP0002255A3 (en) | Bleaching compositions | |
| PL339379A1 (en) | Bleaching compositions | |
| IL121269A0 (en) | Compositions and methods for reversibly increasing permeability of biomembranes | |
| PL341344A1 (en) | Molecular dispersion type compositions of enhanced bioassimillability | |
| ZA988581B (en) | Stable bleaching compositions | |
| HUP0004862A3 (en) | Novel compounds useful as neuro-protective agents | |
| GB9700449D0 (en) | Non-halogenated intumescent compositions | |
| PL337782A1 (en) | Powdered compositions of single-film liposomes | |
| GB9703109D0 (en) | Compositions | |
| AP9901651A0 (en) | Nitro-benzamide useful as anti-arrhytmic agent | |
| GB9710933D0 (en) | Microemulsion compositions | |
| LT97046A (en) | Composition of aperitive ingredients | |
| GB9805675D0 (en) | Preparation of solid lipid compositions | |
| GB9712031D0 (en) | Compositions of matter | |
| GB9709824D0 (en) | Compositions of matter |